ArticleFrontiers in immunology2025

Upadacitinib for refractory Behçet's disease with myelodysplastic syndrome and trisomy 8/9: a case report and mechanistic insights.

Yukai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.